1. Subcutaneous and orthotopic xenograft models of human bladder carcinoma in nude mice for epidermal growth factor receptor-targeted treatment
   M. S. Vorontsova et al, 2018, Russian Journal of Biotherapy CrossRef
2. An Overview of Promising Biomarkers in Cancer Screening and Detection
   Saba Hasan, 2020, Current Cancer Drug Targets CrossRef
3. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
   Christine Mehner et al, 2017, Genes & Cancer CrossRef
4. Recent advances in targeted therapy for pancreatic adenocarcinoma
   Yu-Ting Fang et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
5. Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
   Ryan A Hutchinson et al, 2015, Journal of Translational Medicine CrossRef
6. Neue Therapieprinzipien beim Pankreaskarzinom: Zweitlinientherapie/Second Line, Targeted Therapies
   Alexander Kleger et al, 2013, Erkrankungen des Pankreas CrossRef
7. Smarter drugs emerging in pancreatic cancer therapy
   A. Kleger et al, 2014, Annals of Oncology CrossRef
8. Transient receptor potential vanilloid 1 promotes EGFR ubiquitination and modulates EGFR/MAPK signalling in pancreatic cancer cells
   Jin Huang et al, 2020, Cell Biochemistry and Function CrossRef
9. Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis
   Marcos Vinicius Perini et al, 2015, ANZ Journal of Surgery CrossRef
10. The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
    Meng Guo et al, 2016, International Journal of Molecular Sciences CrossRef
11. Current Adjuvant Therapeutic Approaches for Pancreatic Cancer
    Fusun Ozmen et al, 2015, Advances in Therapy CrossRef
12. New Pharmacological Approaches for Pancreatic Cancer Therapy
    Vineet K. Gupta et al, 2021, Clinical Pancreatology for Practising Gastroenterologists and Surgeons CrossRef